| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000040384 |
| Receipt No. | R000046086 |
| Scientific Title | Role of GSA Scintigraphy to predict liver failure after perihilar cholangiocarcinoma surgery |
| Date of disclosure of the study information | 2020/05/13 |
| Last modified on | 2021/11/19 (Ver. 3) |
| Basic information | ||
| Public title | Role of GSA Scintigraphy to predict liver failure after perihilar cholangiocarcinoma surgery | |
| Acronym | GSA Scintigraphy and PHLF | |
| Scientific Title | Role of GSA Scintigraphy to predict liver failure after perihilar cholangiocarcinoma surgery | |
| Scientific Title:Acronym | GSA Scintigraphy and PHLF | |
| Region |
|
|
| Condition | |||
| Condition | Perihilar cholangiocarcinoma | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Efficiency |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Liver failure-related death |
| Key secondary outcomes | Incidence of liver failure |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with perihilar cholangiocarcinoma surgery in Hokkaido University (Surg II or Gastroenterological surgery II), | |||
| Key exclusion criteria | Data missing | |||
| Target sample size | 183 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Gastroenterological surgery II | ||||||
| Zip code | 0608638 | ||||||
| Address | Kita15 Nishi7, Kitaku, Sapporo city, Japan | ||||||
| TEL | 011-706-7714 | ||||||
| drnoji@med.hokudai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Gastroenterological surgery II | ||||||
| Zip code | 0608638 | ||||||
| Address | Kita15 Nishi7, Kitaku, Sapporo city, Japan | ||||||
| TEL | 011-706-7714 | ||||||
| Homepage URL | |||||||
| drnoji@med.hokudai.ac.jp | |||||||
| Sponsor | |
| Institute | Hokkaido University Hospital, Gastroenterological surgery II |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Selffunding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hokkaido University Hospital Clinical Research and Medical Innovation Center |
| Address | Kita14 Nishi5, Kita-ku, Kita14 Nishi |
| Tel | 011-716-1161 |
| crjimu@huhp.hokudai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://link.springer.com/article/10.1007%2Fs11605-021-05066-2 |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://link.springer.com/article/10.1007%2Fs11605-021-05066-2 | ||||||
| Number of participants that the trial has enrolled | 183 | ||||||
| Results | Efficiency of GSA(LHL15) was shown by this tstudy | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | 183patients were enrolled in this study | ||||||
| Participant flow | None | ||||||
| Adverse events | None | ||||||
| Outcome measures | Show the detail in the paper | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | There were 181 consecutive PHCC patients subjected to major hepatectomy with extrahepatic bile duct resection with or without pancreaticoduodenectomy at Hokkaido University, Dept. of Gastroenterological Surgery II between January 2005 and December 2015. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046086 |